
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1.1B | -- | -- | $1.04 | -- |
07/24/2025 | Q2 | $1.1B | -- | -- | $0.99 | -- |
04/24/2025 | Q1 | $1.1B | $1.1B | $0.75 | $0.98 | -$0.23 |
02/13/2025 | Q4 | $1B | $1B | $0.34 | $0.95 | -$0.61 |
10/23/2024 | Q3 | $1.1B | $1.1B | $0.35 | $1.01 | -$0.66 |
07/25/2024 | Q2 | $1B | $1B | $0.44 | $0.97 | -$0.53 |
04/25/2024 | Q1 | $978M | $1B | $0.33 | $0.81 | -$0.48 |
02/13/2024 | Q4 | $926.1M | $954.3M | $0.03 | $0.71 | -$0.68 |
10/24/2023 | Q3 | -- | -- | -$1.65 | $0.94 | -$2.59 |
07/25/2023 | Q2 | -- | -- | $0.28 | $0.82 | -$0.54 |
04/25/2023 | Q1 | -- | -- | $0.27 | $0.74 | -$0.47 |
02/14/2023 | Q4 | -- | -- | $0.24 | $0.82 | -$0.58 |
10/25/2022 | Q3 | -- | -- | $0.41 | $0.91 | -$0.50 |
07/26/2022 | Q2 | -- | -- | $0.49 | $0.97 | -$0.48 |
04/26/2022 | Q1 | -- | -- | $0.25 | $0.92 | -$0.67 |
02/22/2022 | Q4 | -- | -- | $5.27 | $0.92 | $4.35 |
10/26/2021 | Q3 | -- | -- | $0.59 | $0.93 | -$0.34 |
07/27/2021 | Q2 | -- | -- | $0.66 | $0.91 | -$0.25 |
04/27/2021 | Q1 | -- | -- | $0.66 | $0.80 | -$0.14 |
02/16/2021 | Q4 | -- | -- | $0.53 | $0.79 | -$0.26 |
10/27/2020 | Q3 | -- | -- | $0.53 | $0.76 | -$0.23 |
07/28/2020 | Q2 | -- | -- | $0.36 | $0.50 | -$0.14 |
04/28/2020 | Q1 | -- | -- | $0.37 | $0.67 | -$0.30 |
02/18/2020 | Q4 | -- | -- | $0.43 | $0.72 | -$0.29 |
10/22/2019 | Q3 | -- | -- | $0.48 | $0.71 | -$0.23 |
07/23/2019 | Q2 | -- | -- | $0.69 | $0.65 | $0.04 |
04/23/2019 | Q1 | -- | -- | $0.60 | $0.59 | $0.01 |
02/14/2019 | Q4 | -- | -- | $0.66 | $0.63 | $0.03 |
10/23/2018 | Q3 | -- | -- | $0.65 | $0.63 | $0.02 |
07/24/2018 | Q2 | -- | -- | $0.62 | $0.60 | $0.02 |
04/20/2018 | Q1 | -- | -- | $0.57 | $0.52 | $0.05 |
02/13/2018 | Q4 | -- | -- | $0.50 | $0.48 | $0.02 |
10/27/2017 | Q3 | -- | -- | $0.49 | $0.46 | $0.03 |
06/30/2017 | Q2 | -- | -- | $0.47 | $0.44 | $0.03 |
TransUnion reported $1.1B worth of top line sales in its most recent quarter.
TransUnion announced earnings per share of $0.75 which represents a miss of analyst forecast a $0.98 per share.
TransUnion reported $650.1M that represents $3.30 per share over the last quarter.
TransUnion's earnings are forecast to grow from $1.45 per share to $3.88 per share next year representing an increase of 182.48%.
TransUnion's next earnings date is July 24, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.